These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 6817241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats.
    Commissaris RL, Lyness WH, Moore KE, Rech RH.
    Pharmacol Biochem Behav; 1981 May; 14(5):595-601. PubMed ID: 7243838
    [Abstract] [Full Text] [Related]

  • 3. Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride.
    Mokler DJ, Rech RH.
    Pharmacol Biochem Behav; 1984 Aug; 21(2):281-7. PubMed ID: 6483939
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs.
    Mokler DJ, Stoudt KW, Rech RH.
    Pharmacol Biochem Behav; 1985 May; 22(5):677-82. PubMed ID: 3859879
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB, Rutledge MA, Carbonaro T, Forster MJ.
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [Abstract] [Full Text] [Related]

  • 10. Differential antagonism by metergoline of the behavioral effects of indolealkylamine and phenethylamine hallucinogens in the rat.
    Commissaris RL, Lyness WH, Moore KE, Rech RH.
    J Pharmacol Exp Ther; 1981 Oct; 219(1):170-4. PubMed ID: 6793709
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
    Adams LM, Geyer MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Oct; 9(2):121-32. PubMed ID: 3858911
    [Abstract] [Full Text] [Related]

  • 13. Neurophysiological effects of hallucinogens on serotonergic neuronal systems.
    McCall RB.
    Neurosci Biobehav Rev; 1982 Oct; 6(4):509-14. PubMed ID: 7177511
    [Abstract] [Full Text] [Related]

  • 14. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D, Palumbo PA, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [Abstract] [Full Text] [Related]

  • 15. Neurological aspects of hallucinogenic drugs.
    Logan WJ.
    Adv Neurol; 1975 May; 13():47-78. PubMed ID: 814800
    [No Abstract] [Full Text] [Related]

  • 16. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME, Heym J, Jacobs BL.
    Brain Res; 1981 Jun 29; 215(1-2):275-93. PubMed ID: 6114779
    [Abstract] [Full Text] [Related]

  • 17. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ, Commissaris RL, Warner MR, Rech RH.
    J Pharmacol Exp Ther; 1983 Dec 29; 227(3):557-62. PubMed ID: 6655557
    [Abstract] [Full Text] [Related]

  • 18. The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM).
    Mokler DJ, Stoudt KW, Sherman LC, Rech RH.
    Pharmacol Biochem Behav; 1987 Nov 29; 28(3):327-34. PubMed ID: 3685066
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL, Trulson ME, Stark AD, Christoph GR.
    Commun Psychopharmacol; 1977 Nov 29; 1(3):243-54. PubMed ID: 272265
    [No Abstract] [Full Text] [Related]

  • 20. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.
    Appel JB, White FJ, Holohean AM.
    Neurosci Biobehav Rev; 1982 Nov 29; 6(4):529-36. PubMed ID: 7177512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.